Tuesday, May 09, 2023 12:17:55 PM
Such is the education/learning curve of hotly debated IP litigation. But what makes this stock special is that at the FOUNDATION - we have some extremely strong points: Try as they May - Apple and all of the major silicon valley giants have FAILED to put an end to VPLM. And OH have they tried.
Yet PTAB, and actual IP experts continually validate and re-validate these patents.
Yes - using all of the might and political insidership (shouldn't be a thing, but it undeniably is) in the Northern Cal District courts - Apple had some success using dirty tricks that shut down VPLM arguments before even giving them a basic hearing.
NOW - and in large part - DUE to an intense hatred of Patent-owner abuses in NCDA, we have a champion of a Judge in Waco, whose life's work is largely dedicated to seeing that Patent Litigation is handled fairly and even-handedly.
We've never looked for an unfair advantage - Just a proper hearing. Is that so much to ask?
Apparently so, in NCDA
So, likely, we'll continue to see small runs, smacking of tired, but fervent hope - spiked temporarily by daytraders who love to play with a stock that's moving for short term gains - then returning to an ever-increasing status quo level - right up till that moment when, inevitably at this point, the details of a settlement agreement are made public - at which point, I anticipate a sharp, long-term and almost instant rise in the pps, creating a new "baseline" - from which all new gains will be measured, as additional infringers read the writing on the wall and fall in line - or a buyout, likely from one of the largest infringers, takes place - in which case, shares will likely be frozen, and monetized.
If this were a "fake" ... "troll"... etc., the opportunity for that to be proven has long since come and gone. The question is: How much can you spare, right now, for a no-brainer that might take a little time? IMHO
Recent VPLM News
- ILUS International Inc (ILUS) Sees 557% Q1 Revenue Increase, Begins National Exchange Uplist Procedure for Subsidiaries and Company • InvestorsHub NewsWire • 06/05/2023 12:15:00 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM